Chemical adjuvants for plasmid DNA vaccines

被引:123
作者
Greenland, John R. [1 ]
Letvin, Norman L. [1 ]
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA
关键词
plasmid DNA; vaccine; adjuvant; polymer; BIODEGRADABLE ALGINATE MICROSPHERES; HUMORAL IMMUNE-RESPONSES; CYTOTOXIC T-LYMPHOCYTES; DIRECT GENE-TRANSFER; IN-VIVO; DENDRITIC CELLS; CATIONIC MICROPARTICLES; ANTIGEN PRESENTATION; PROTECTIVE IMMUNITY; PHASE-I;
D O I
10.1016/j.vaccine.2007.01.120
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plasmid DNA vaccines are a promising modality for immunization against a variety of human pathogens. Immunization via multiple routes with plasmid DNA can elicit potent cellular immune responses, and these immunogens can be administered repeatedly without inducing anti-vector immunity. Nonetheless, the immunogenicity of plasmid DNA vaccines has been limited by problems associated with delivery. A number of adjuvants have been designed to improve plasmid DNA immunogenicity, either by directly stimulating the immune system or by enhancing plasmid DNA expression. Chemical adjuvants for enhancing plasmid DNA expression include liposomes, polymers, and microparticles, all of which have shown promise for enhancing the expression and immunogenicity of plasmid DNA vaccines in animal models. Micro- and nanoparticles have not been shown to enhance immune responses to plasmid DNA vaccines. However, formulation of plasmid DNA with some non-particulate polymeric adjuvants has led to a statistically significant enhancement of immune responses. Further development of these technologies will significantly improve the utility of plasmid DNA vaccination. (C) 2007 Published by Elsevier Ltd.
引用
收藏
页码:3731 / 3741
页数:11
相关论文
共 141 条
[1]  
Aggarwal N, 1999, CAN J VET RES, V63, P148
[2]   A polymer library approach to suicide gene therapy for cancer [J].
Anderson, DG ;
Peng, WD ;
Akinc, A ;
Hossain, N ;
Kohn, A ;
Padera, R ;
Langer, R ;
Sawicki, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (45) :16028-16033
[3]   Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery [J].
Anderson, DG ;
Lynn, DM ;
Langer, R .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (27) :3153-3158
[4]  
André S, 1998, J VIROL, V72, P1497
[5]   Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines [J].
Anwer, K ;
Earle, KA ;
Shi, M ;
Wang, JJ ;
Mumper, RJ ;
Proctor, B ;
Jansa, K ;
Ledebur, HC ;
Davis, S ;
Eaglstein, W ;
Rolland, AP ;
Rolland, P .
PHARMACEUTICAL RESEARCH, 1999, 16 (06) :889-895
[6]   Novel signal transduction pathway utilized by extracellular HSP70 -: Role of Toll-like receptor (TLR) 2 AND TLR4 [J].
Asea, A ;
Rehli, M ;
Kabingu, E ;
Boch, JA ;
Baré, O ;
Auron, PE ;
Stevenson, MA ;
Calderwood, SK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (17) :15028-15034
[7]   Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines [J].
Babiuk, S ;
Baca-Estrada, ME ;
Foldvari, M ;
Middleton, DM ;
Rabussay, D ;
Widera, G ;
Babiuk, LA .
JOURNAL OF BIOTECHNOLOGY, 2004, 110 (01) :1-10
[8]   Two methods for quantifying DNA extracted from poly(lactide-co-glycolide) microspheres [J].
Barman, SP ;
Lunsford, L ;
Chambers, P ;
Hedley, ML .
JOURNAL OF CONTROLLED RELEASE, 2000, 69 (03) :337-344
[9]   The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses [J].
Barouch, DH ;
Letvin, NL ;
Seder, RA .
IMMUNOLOGICAL REVIEWS, 2004, 202 :266-274
[10]   Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines [J].
Barouch, DH ;
McKay, PF ;
Sumida, SM ;
Santra, S ;
Jackson, SS ;
Gorgone, DA ;
Lifton, MA ;
Chakrabarti, BK ;
Xu, L ;
Nabel, GJ ;
Letvin, NL .
JOURNAL OF VIROLOGY, 2003, 77 (16) :8729-8735